Navigation Links
New !! “Designer” Gene Theray

Gene therapy works by inserting modified genes to treat an illness or condition into a virus that has been made harmless to humans.
But injecting these gene-carrying viruses into a person’s bloodstream has been a problem, because most of the virus ends up in the liver, which naturally isolates foreign bodies and washes them out of the blood.// That makes it difficult to deliver enough of the new genes to the part of the body that needs assistance.

New research shows a form of gene therapy capable of entering the bloodstream and traveling directly to the part of the body that needs treatment may be on the horizon.

Scientists from the University of Glasgow in Scotland have now developed a “designer” gene therapy that bypasses the liver. The new therapy uses an adeno-associated virus, or AAV, which has been redesigned to avoid capture by the liver long enough to get to the part of the body needing the new genes.They’ve tested two forms of the virus in the laboratory and in mice, using it to deliver new genes to vascular endothelial cells, which are the cells that line the inside of blood vessels. These cells play a major role in many cardiovascular abnormalities. Researchers redesigned the virus by modifying two small proteins called peptides.

More work will be needed before the therapy can be tried in humans, but researchers believe these findings hold promise for the future.
'"/>




Page: 1

Related medicine news :

1. Low Birth Weight infants could have Problems in the Future
2. New Virus : A Threat In the Future?
3. Will Your Baby Grow Up To Be A Future Einstein ?
4. Genetic Pills A Future Thought
5. Prediction Of Disease In The Future Questioned
6. Asthmatics May Be At Risk for Lung Disease In The Future
7. Eyes,The Window To The Future
8. Use Of Sunscreen In Childhood And Prevents Future Skin Cancer
9. Childrens Waistlines A Predictor Of Future Heart Disease
10. Recent Study On Rats May Lead To Future Robotics
11. Predicting The Risk Of Breast Cancer In The Future
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: